Participant Information Sheet
Version  
Re: Nurse perceptions of potential occupational exposure to cytotoxic drugs study
I would like to invite you to take part a research study. Before you decide I would like you to understand why the research is being done and what it would involve for you.
What is the purpose of the study?
The purpose of the study is to explore cancer nurse perceptions of potential occupational exposure to cytotoxic drugs
Why have I been invited?
In this study we will invite 30 people to participate. We have asked you to participate in this study because you have identified that you are a cancer nurse that has handled and administered cytotoxic drugs in your career to date.
We would like to hear what your thoughts and feelings are about your perception and experience of being a cancer nurse that has handled and administered cytotoxic drugs.
Do I have to take part?
It is up to you to decide to join the study. If you agree to take part, they will then ask you to sign a consent form. You are free to withdraw at any time, without giving a reason. This would not affect any participation in other future projects or your role as a health care professional.
What will happen to me if I take part?
If you wish to take part in this study the research team will invite you to participate in an online or telephone interview at a time most convenient to yourself. Before the interview we can give you more information about the study and a consent form will be emailed to you. We will ask you to email this back and at the beginning of the interview you will be asked again for your consent to proceed.
In the interview I would ask you to describe your experience and perception of potential exposure to cytotoxic drugs whilst delivering care.
What will happen if I don’t want to carry on with the study?
During the interview if you do not want to carry on with the study, the interview will be stopped and all the data collected and contact details will be destroyed and no further contact will be made about the study.
What if there is a problem?
If you have a concern about any aspect of this study, you should speak to the researcher who will do their best to answer your questions, please contact D.Dicksit@napier.ac.uk . If you remain unhappy and wish to complain formally, you can do this from Edinburgh Napier University’s Appeals, Complaints and Conduct Manager. Details can be obtained from firstname.lastname@example.org . If you find yourself requiring support after this interview please contact M.Dunham@napier.ac.uk
Will my taking part in the study be kept confidential?
Yes. We will follow ethical and legal practice and all information about you will be handled in confidence. Your contact details will be destroyed shortly after the interview. All the digital recordings will be removed from the recorder and placed on a password protected computer and anonymised for analysis.
Who will see my personal information?
No one will see your personal information. The audio recording will be anonymised and placed on a password protected computer to enable the researcher to perform the analysis. All information collected through interviews will remain will be held according to Edinburgh Napier University procedures for ensuring confidential and anonymous storage of information.
How will it help patient care if I participate in this project?
By sharing your valuable experience we can collect data that will help us to understand and make recommendations for future cytotoxic practice.
What will happen to the results of the research study?
The intention of the study is to publish the findings in an academic journal and present these at the UK Oncology Nursing Society’s annual conference. The findings will be presented so that you will not be identifiable.
Who has reviewed the study?
All university research is looked at by independent group of people, called a Research Ethics Committee, to protect your interests. This study has been reviewed and given a favourable opinion by Edinburgh Napier University Research Ethics Committee.
Thank you for taking the time to read this information sheet and I hope that you will consider participating in this project.
Further information and contact details:
If you need any further information about the study, contact details are below:
|Main Researcher||Independent Advisor|
| Dr Karen Campbell
|Dr. Coral Hanson